These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 17893283)

  • 21. Postmenopausal hormone therapy and the risk of breast cancer: a contrary thought.
    Speroff L
    Menopause; 2008; 15(2):393-400. PubMed ID: 17925662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: The ESTHER study.
    Canonico M; Olié V; Carcaillon L; Tubert-Bitter P; Scarabin PY;
    Thromb Haemost; 2008 Jan; 99(1):246-8. PubMed ID: 18217166
    [No Abstract]   [Full Text] [Related]  

  • 23. Estrogen and progestogen therapy in postmenopausal women.
    Practice Committee of the American Society for Reproductive Medicine
    Fertil Steril; 2006 Nov; 86(5 Suppl 1):S75-88. PubMed ID: 17055850
    [No Abstract]   [Full Text] [Related]  

  • 24. [Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk].
    von Schoultz B
    Lakartidningen; 2009 Aug 19-25; 106(34):2041-2. PubMed ID: 19769143
    [No Abstract]   [Full Text] [Related]  

  • 25. Landmark hormone replacement therapy study stopped after finding more harms than benefits.
    Rollins G
    Rep Med Guidel Outcomes Res; 2002 Aug; 13(15):5-7. PubMed ID: 12553323
    [No Abstract]   [Full Text] [Related]  

  • 26. An open-label study of subdermal implants of estradiol-only versus subdermal implants of estradiol plus nomegestrol acetate: effects on symptom control, lipid profile and tolerability.
    Barbosa IC; Coutinho EM; Oladapo L; Noronha CF; Mota RL; Lopes AC; Lopes RC
    Gynecol Endocrinol; 2009 Apr; 25(4):269-75. PubMed ID: 19408176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy.
    Roach RE; Lijfering WM; Helmerhorst FM; Cannegieter SC; Rosendaal FR; van Hylckama Vlieg A
    J Thromb Haemost; 2013 Jan; 11(1):124-31. PubMed ID: 23136837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rationale for use of lower estrogen doses for postmenopausal hormone therapy.
    Ettinger B
    Maturitas; 2007 May; 57(1):81-4. PubMed ID: 17383126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormone therapy and risk of venous thromboembolism among postmenopausal women.
    Canonico M
    Maturitas; 2015 Nov; 82(3):304-7. PubMed ID: 26276103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progestogens and venous thromboembolism among postmenopausal women using hormone therapy.
    Canonico M; Plu-Bureau G; Scarabin PY
    Maturitas; 2011 Dec; 70(4):354-60. PubMed ID: 22024394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration.
    Bergendal A; Kieler H; Sundström A; Hirschberg AL; Kocoska-Maras L
    Menopause; 2016 Jun; 23(6):593-9. PubMed ID: 27023862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormone therapy and venous thromboembolism among postmenopausal women.
    Scarabin PY
    Front Horm Res; 2014; 43():21-32. PubMed ID: 24943295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ACOG committee opinion no. 556: Postmenopausal estrogen therapy: route of administration and risk of venous thromboembolism.
    Obstet Gynecol; 2013 Apr; 121(4):887-890. PubMed ID: 23635705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HRT and venous thromboembolism: more evidence of a link.
    Chen BH
    CMAJ; 2001 Jan; 164(1):87. PubMed ID: 11202677
    [No Abstract]   [Full Text] [Related]  

  • 35. Postmenopausal hormone replacement therapy and venous thromboembolism.
    Wu O
    Gend Med; 2005; 2 Suppl A():S18-27. PubMed ID: 16551553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER Study.
    Canonico M; Oger E; Conard J; Meyer G; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
    J Thromb Haemost; 2006 Jun; 4(6):1259-65. PubMed ID: 16706969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of raloxifene therapy on venous thromboembolism in postmenopausal women. A meta-analysis.
    Adomaityte J; Farooq M; Qayyum R
    Thromb Haemost; 2008 Feb; 99(2):338-42. PubMed ID: 18278183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EMAS position statement: managing obese postmenopausal women.
    Lambrinoudaki I; Brincat M; Erel CT; Gambacciani M; Moen MH; Schenck-Gustafsson K; Tremollieres F; Vujovic S; Rees M; Rozenberg S
    Maturitas; 2010 Jul; 66(3):323-6. PubMed ID: 20434858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postmenopausal Hormone Therapy and Risk of Stroke: Impact of the Route of Estrogen Administration and Type of Progestogen.
    Canonico M; Carcaillon L; Plu-Bureau G; Oger E; Singh-Manoux A; Tubert-Bitter P; Elbaz A; Scarabin PY
    Stroke; 2016 Jul; 47(7):1734-41. PubMed ID: 27256671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guidelines for hormone treatment of women in the menopausal transition and beyond.
    Naftolin F; Schneider HP; Sturdee DW;
    Maturitas; 2005 May; 51(1):15-20. PubMed ID: 15883104
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.